Elite controllers as a model for a cure of HIV-1 infection
Elite controllers as a model for a cure of HIV-1 infection
批准号:
10461864
负责人:
Xu Yu
金额:
$86.56万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-23 至 2026-08-31
关键词:
ATAC-seqAddressAgeAllogeneic Bone Marrow TransplantationAnti-Retroviral AgentsBehaviorBiological AssayBloodCCR5 geneCellsCellular AssayChIP-seqCharacteristicsChromatinComplexDNADNA MethylationDataDisease OutcomeDisease remissionEpigenetic ProcessFrequenciesGeneticGenetic TranscriptionGenomeGenomic SegmentGoalsHIVHIV-1HLA Class I GenesHematopoietic stem cellsHistonesHumanHuman GenomeHypermethylationImmuneImmune responseImmunologicsIndividualInfectionInterventionLinkLymphoid TissueMediatingMethylationModelingMolecular ProfilingNaturePathogenicityPeripheral Blood Mononuclear CellPharmaceutical PreparationsPredispositionProvirusesRNAReportingResearchResistanceRunningSignal TransductionSiteStem cell transplantStimulusStructureStudy modelsTechniquesTechnologyTestingTimeTissuesVariantViralViral GenesViral Load resultViral reservoirViremiaVirusbiocomputingchromosomal locationclinical developmentdesignexperimental studygenome analysisgenome-widegenomic locusin vivoinnovationintegration siteinterestlongitudinal analysisnext generation sequencingnovelpatient populationpermissivenesspromoter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
While a sterilizing cure of HIV-1 infection has been reported in two individuals after a stem cell transplant with
CCR5∆32 homozygous cells, a spontaneous functional cure of HIV-1 occurs in 0.3-0.5% of all infected
individuals. These individuals, termed elite controllers (EC), maintain undetectable levels of HIV-1 replication in
the absence of treatment, despite the repeated isolation of replication-competent virus from viral reservoir cells.
These individuals provide living evidence that spontaneous control of HIV-1 infection is possible, and the
identification of virological and immunological mechanisms underlying such a remarkable disease outcome holds
promise for inducing a functional cure of HIV-1 infection in broader HIV-1 patient populations. Here, we propose
the novel hypothesis that undetectable viral loads in EC are related to specific genetic and epigenetic features
of proviral HIV-1 DNA in reservoir cells. Based on strong preliminary data, we posit that intact HIV-1 proviruses
from EC are preferentially located in non-genic chromosomal regions that do not permit effective viral gene
transcription, resulting in a proviral landscape in deep latency and with very limited responsiveness to
reactivation stimuli in vivo. In addition, we propose that intact proviruses from EC are also frequently integrated
into chromosomal regions that show epigenetic characteristics of repressive chromatin, evidenced by enhanced
distance to accessible chromatin and enrichment with inhibitory histone marks and hypermethylated DNA. To
investigate this, we plan to longitudinally analyze the frequency and chromosomal location of intact proviruses
in blood and lymphoid tissues of EC, using novel experimental and biocomputational analysis approaches
(Specific Aim 1). In addition, we will conduct a detailed analysis of epigenetic chromatin features at the
integration sites of intact proviruses, using next-generation sequencing assays for genome-wide characterization
of chromatin accessibility, RNA transcription, activating and inhibitory histone marks, and DNA methylation
(Specific Aim 2). Finally, we will perform functional experiments to evaluate responsiveness to viral reactivation
stimuli, using novel single-cell assays to simultaneously characterize proviral sequence, chromosomal
integration sites and HIV-1 transcriptional activity of single viral reservoir cells (Specific Aim 3); these highly
innovate single-reservoir-cell assays will allow to functionally test the hypothesis that chromosomal locations of
intact proviruses in EC maintain a state of deep latency and confer resistance to viral reactivation stimuli. If
successful, this project will significantly expand our current understanding of how natural, drug-free control is
possible, and be highly informative for inducing natural control in broader patient populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elite controllers as a model for a cure of HIV-1 infection
-
批准号:10269041
-
项目类别:
-
资助金额:$86.76万
-
财政年份:2020
-
负责人:Xu Yu
-
依托单位:
Elite controllers as a model for a cure of HIV-1 infection
-
批准号:10161195
-
项目类别:
-
资助金额:$88.72万
-
财政年份:2020
-
负责人:Xu Yu
-
依托单位:
A systems biology approach to fingerprint HIV immune defense in Elite Controllers
-
批准号:9336341
-
项目类别:
-
资助金额:$82.33万
-
财政年份:2016
-
负责人:Xu Yu
-
依托单位:
A systems biology approach to fingerprint HIV immune defense in Elite Controllers
-
批准号:9204504
-
项目类别:
-
资助金额:$85.99万
-
财政年份:2016
-
负责人:Xu Yu
-
依托单位:
Targeting HIV-1 persistence with Interferon-a
-
批准号:9292717
-
项目类别:
-
资助金额:$51.3万
-
财政年份:2016
-
负责人:Xu Yu
-
依托单位:
T memory stem cell aging in HIV-1 infection
-
批准号:8650023
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2014
-
负责人:Xu Yu
-
依托单位:
A systems biology approach to fingerprint HIV immune defense in Elite Controllers
-
批准号:8915895
-
项目类别:
-
资助金额:$88.56万
-
财政年份:2014
-
负责人:Xu Yu
-
依托单位:
Targeting HIV-1 persistence with Interferon-a
-
批准号:8842365
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2014
-
负责人:Xu Yu
-
依托单位:
A systems biology approach to fingerprint HIV immune defense in Elite Controllers
-
批准号:8527131
-
项目类别:
-
资助金额:$72.74万
-
财政年份:2012
-
负责人:Xu Yu
-
依托单位:
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells
-
批准号:8312490
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2010
-
负责人:Xu Yu
-
依托单位:
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells
-
批准号:8012425
-
项目类别:
-
资助金额:$42.69万
-
财政年份:2010
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:8141637
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2010
-
负责人:Xu Yu
-
依托单位:
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells
-
批准号:8516442
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2010
-
负责人:Xu Yu
-
依托单位:
A Microengraving Technology for the Study of Latently HIV-infected Primary Cells
-
批准号:8142976
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2010
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:7554568
-
项目类别:
-
资助金额:$44.8万
-
财政年份:2008
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:7640745
-
项目类别:
-
资助金额:$44.98万
-
财政年份:2008
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:8291956
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2008
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:7880019
-
项目类别:
-
资助金额:$43.69万
-
财政年份:2008
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:8105076
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2008
-
负责人:Xu Yu
-
依托单位:
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection
-
批准号:8732047
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2008
-
负责人:Xu Yu
-
依托单位:
海外基金